SPIA
ABBV icon

Steward Partners Investment Advisory’s AbbVie ABBV Stock Holding History

Steward Partners Investment Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$95M Buy
436,916
+31,840
+8% +$7.06M 0.48% 35
2025
Q4 		$92.6M Buy
405,076
+49,878
+14% +$11.4M 0.51% 32
2025
Q3 		$82.2M Buy
355,198
+13,062
+4% +$2.66M 0.47% 37
2025
Q2 		$63.5M Buy
342,136
+70,051
+26% +$13M 0.5% 32
2025
Q1 		$57M Buy
272,085
+1,907
+0.7% +$371K 0.5% 36
2024
Q4 		$48M Buy
270,178
+21,250
+9% +$3.91M 0.43% 42
2024
Q3 		$49.2M Buy
248,928
+25,034
+11% +$4.67M 0.45% 41
2024
Q2 		$38.4M Buy
223,894
+6,350
+3% +$1.05M 0.4% 46
2024
Q1 		$39.6M Buy
217,544
+9,975
+5% +$1.72M 0.44% 46
2023
Q4 		$32.2M Buy
207,569
+33,489
+19% +$4.88M 0.43% 48
2023
Q3 		$25.9M Sell
174,080
-4,160
-2% -$611K 0.4% 52
2023
Q2 		$24M Sell
178,240
-1,642
-0.9% -$241K 0.36% 56
2023
Q1 		$28.7M Buy
179,882
+232
+0.1% +$35.5K 0.46% 41
2022
Q4 		$29M Sell
179,650
-1,235
-0.7% -$189K 0.49% 37
2022
Q3 		$24.3M Buy
180,885
+2,489
+1% +$357K 0.45% 46
2022
Q2 		$27.3M Sell
178,396
-14,589
-8% -$2.23M 0.5% 37
2022
Q1 		$31.3M Sell
192,985
-167
-0.1% -$24.3K 0.48% 36
2021
Q4 		$26.2M Buy
193,152
+6,406
+3% +$757K 0.4% 46
2021
Q3 		$20.1M Buy
186,746
+15,235
+9% +$1.74M 0.35% 59
2021
Q2 		$19.3M Buy
171,511
+21,997
+15% +$2.48M 0.33% 60
2021
Q1 		$16.2M Buy
149,514
+27,818
+23% +$2.98M 0.28% 80
2020
Q4 		$13M Buy
121,696
+11,176
+10% +$1.07M 0.28% 88
2020
Q3 		$9.68M Buy
110,520
+7,651
+7% +$720K 0.24% 105
2020
Q2 		$10.1M Buy
102,869
+10,482
+11% +$923K 0.29% 87
2020
Q1 		$7.04M Buy
92,387
+5,478
+6% +$467K 0.26% 100
2019
Q4 		$7.69M Buy
86,909
+1,132
+1% +$94K 0.23% 107
2019
Q3 		$6.5M Sell
85,777
-20,905
-20% -$1.43M 0.22% 109
2019
Q2 		$7.76M Buy
106,682
+4,075
+4% +$320K 0.28% 88
2019
Q1 		$8.27M Buy
102,607
+5,233
+5% +$428K 0.35% 70
2018
Q4 		$8.98M Sell
97,374
-16,964
-15% -$1.49M 0.44% 57
2018
Q3 		$10.8M Buy
114,338
+22,427
+24% +$2.13M 0.52% 35
2018
Q2 		$8.52M Buy
91,911
+30,014
+48% +$2.93M 0.51% 38
2018
Q1 		$5.86M Sell
61,897
-4,419
-7% -$485K 0.4% 50
2017
Q4 		$6.41M Buy
66,316
+1,561
+2% +$147K 0.49% 40
2017
Q3 		$5.75M Buy
64,755
+3,146
+5% +$239K 0.59% 37
2017
Q2 		$4.47M Buy
61,609
+19,902
+48% +$1.34M 0.5% 54
2017
Q1 		$2.72M Buy
41,707
+22,908
+122% +$1.44M 0.41% 62
2016
Q4 		$1.18M Buy
+18,799
New +$1.15M 0.54% 38

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Steward Partners Investment Advisory's ABBV Position: Q1 2026 in Review

Steward Partners Investment Advisory increased its AbbVie (ABBV) stake by 7.9% in Q1 2026, buying an estimated $7.06M and bringing the position to 436,916 shares worth $95M. The position accounts for 0.48% of the portfolio, ranked #35.

Steward Partners Investment Advisory first reported a position in ABBV in Q4 2016 and has held it in 38 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Steward Partners Investment Advisory held 436,916 shares of AbbVie worth $95M as of Q1 2026.
  • Steward Partners Investment Advisory bought 31,840 AbbVie shares in Q1 2026, an estimated $7.06M.
  • AbbVie made up 0.48% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #35 holding.
  • Steward Partners Investment Advisory first reported a position in AbbVie in Q4 2016 and has held it in 38 quarters since.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.